History
Explore our Journey of Excellence in Pharmaceutical Manufacturing.
Tianming Pharmaceuticals: to be a global pharmaceutical leader driven by innovation
Tianming Pharmaceuticals is a high-tech enterprise focusing on the research and development, production and sales of new drugs. Our company owns three major production bases as well as two major R&D centers. In addition, the company has established sales subsidiaries in India and Bangladesh, and has established extensive business contacts with partners in many countries around the world.
In the field of R&D, Tianming Pharmaceuticals has a R&D team of more than 100 professional talents, dedicated to the research and development of antibiotics and diabetes drugs, and its R&D level is in a leading position in China. Our company has unique technical advantages in the production process of pharmaceutical raw materials and intermediates, and has passed the ISO9001 international quality system certification, ensuring high standards and continuous innovation of product quality.
Our Development History
2010
Pingyuan County Sihuan Pharmaceutical Co., Ltd. was established
2015
Jinan R&D Company was established
2017
June: Shandong Sihuan Pharmaceutical Co., Ltd. was established
August: Invested and registered in India to build Bulat Pharmaceuticals Co., Ltd.
2018
Guangxi Tianming Pharmaceutical Co., Ltd. was established; Shandong Sihuan was approved as a national high-tech enterprise
2019
Jining Tianming Pharmaceutical Co., Ltd. was established
2020
Shandong Tianming Pharmaceutical Group was established
2021
The research buildings of Nanjing Company and Jinan Company were put into use
2022
The IPD management system was launched
2023
Guangxi Company was put into production and information construction began
Our Culture
Corporate Vision
To develop innovative medicines and realize the dream of health
Corporate Mission
To contribute to the healthy life of human society while pursuing the material and spiritual happiness of all employees
Corporate Values
Honesty and Trustworthiness, Unity and Mutual Assistance, Pragmatism and Responsibility, Innovation and Progress
What's News
Latest News at Tianming
Hidden Traps Inside An OOS Investigation On Incoming Lots
An OOS investigation on incoming material is a decision process, not a verdict on the batch. This guide walks the buyer’s path: freeze the lot, separate laboratory error from material failure, retest within the rules, and know when a third-party result is worth paying for.
Independent Lab Testing: Proven Proof And The Blind Spots
Independent lab testing settles a dispute between two results, but only if the method and the standard were agreed before the sample left the building. It cannot confirm sample integrity, and it cannot vouch for a process it never saw.
Proven Checks Buyers Miss In A Batch Manufacturing Record
The first commercial batch from a new intermediate supplier is not a formality. Here is the checklist, the five approval outcomes, and how to log the call.
